1344 N17350 combines selective cancer killing with adaptive immune activation to eradicate tumors

Bibliographic Details
Main Authors: Christine Lee, Nicole Grigaitis, Nicole Martinez, Maria Fumagalli, Chang Cui, Ravindra Gujar, Arezoo Arjmand, Catherine Reardon, Kelly Schoenfelt, Sonia Feau, Lev Becker
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1797629540069015552
author Christine Lee
Nicole Grigaitis
Nicole Martinez
Maria Fumagalli
Chang Cui
Ravindra Gujar
Arezoo Arjmand
Catherine Reardon
Kelly Schoenfelt
Sonia Feau
Lev Becker
author_facet Christine Lee
Nicole Grigaitis
Nicole Martinez
Maria Fumagalli
Chang Cui
Ravindra Gujar
Arezoo Arjmand
Catherine Reardon
Kelly Schoenfelt
Sonia Feau
Lev Becker
author_sort Christine Lee
collection DOAJ
first_indexed 2024-03-11T10:54:52Z
format Article
id doaj.art-095ee82a6ed6457695deff934997acac
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-03-11T10:54:52Z
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-095ee82a6ed6457695deff934997acac2023-11-13T10:05:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.13441344 N17350 combines selective cancer killing with adaptive immune activation to eradicate tumorsChristine Lee0Nicole Grigaitis1Nicole Martinez2Maria Fumagalli3Chang Cui4Ravindra Gujar5Arezoo Arjmand6Catherine Reardon7Kelly Schoenfelt8Sonia Feau9Lev Becker10Office of the Commissioner, Office of Minority Health and Health Equity, US Food and Drug Administration, Silver Spring, Maryland, USAOncoMyx Therapeutics, Phoenix, AZ, United StatesCenter for Biomedical Ethics, Stanford University School of Medicine, Stanford, California, USAHibercell, Inc., Roseville, MN, United States1Onchilles Pharma, San Diego, CA, USA1Onchilles Pharma, San Diego, CA, USA1Onchilles Pharma, San Diego, CA, USA2University of Chicago, Chicago, IL, USA2University of Chicago, Chicago, IL, USA1Onchilles Pharma, San Diego, CA, USA1Onchilles Pharma, San Diego, CA, USA
spellingShingle Christine Lee
Nicole Grigaitis
Nicole Martinez
Maria Fumagalli
Chang Cui
Ravindra Gujar
Arezoo Arjmand
Catherine Reardon
Kelly Schoenfelt
Sonia Feau
Lev Becker
1344 N17350 combines selective cancer killing with adaptive immune activation to eradicate tumors
Journal for ImmunoTherapy of Cancer
title 1344 N17350 combines selective cancer killing with adaptive immune activation to eradicate tumors
title_full 1344 N17350 combines selective cancer killing with adaptive immune activation to eradicate tumors
title_fullStr 1344 N17350 combines selective cancer killing with adaptive immune activation to eradicate tumors
title_full_unstemmed 1344 N17350 combines selective cancer killing with adaptive immune activation to eradicate tumors
title_short 1344 N17350 combines selective cancer killing with adaptive immune activation to eradicate tumors
title_sort 1344 n17350 combines selective cancer killing with adaptive immune activation to eradicate tumors
work_keys_str_mv AT christinelee 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors
AT nicolegrigaitis 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors
AT nicolemartinez 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors
AT mariafumagalli 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors
AT changcui 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors
AT ravindragujar 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors
AT arezooarjmand 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors
AT catherinereardon 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors
AT kellyschoenfelt 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors
AT soniafeau 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors
AT levbecker 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors